Inversely and adaptively planned interstitial brachytherapy: A single implant approach

Alexander N. Hanania, Pamela Myers, Alison K. Yoder, Ahmet Bulut, Z. Henry Yu, Salman Eraj, John Bowers, Mark D. Bonnen, Alfredo Echeverria, Tracilyn R. Hall, Matthew L. Anderson, Michelle Ludwig

Research output: Contribution to journalArticlepeer-review

3 Scopus citations


Objective: To evaluate the efficacy, feasibility and safety of image-based, inversely and adaptively planned high-dose rate interstitial brachytherapy (HDR-ISBT) to treat advanced primary or recurrent gynecologic malignancy in a single implant, three-consecutive-day regimen. Methods: Clinical demographics and outcome data were abstracted from all patients with primary and recurrent gynecologic malignancies who received HDR-ISBT boost from 2014 to 2017. Treatment consisted of a single implant (~7 Gy × 4 fractions) of interstitial needles using the Syed-Neblett template over a three-day hospital admission. CT-based (3D) simulation with inverse and adaptive planning was utilized for each fraction. MR prior to and MR immediately after external beam therapy were fused for HDR-ISBT target delineation. Results: Forty women with an overall median follow-up of 18 months (range: 6–54 months) received an HDR-ISBT boost. Of the 30 primary cases (83% cervix, 10% vaginal, 7% uterine), 44% had organ invasion (bladder, rectal or both) on MRI. Median coverage and dose are reported (V100: 98%, HR-CTV EQD2: 85.1 Gy, D90: 92 Gy). A significant association existed between rectal doses exceeding GEC-ESTRO recommendations (D2cc < 75 Gy) and the development of grade 3 gastrointestinal toxicity with a relative risk of 1.4 [1.1–1.8] (p =.046). Actuarial two-year overall survival (OS), local control (LC) and progression-free survival (PFS) were 81%, 81% and 64%, respectively. Conclusions: A four fraction, inversely and adaptively planned, single-implant approach of image-based HDR-ISBT provides excellent coverage, minimal toxicity and effective local control in patients with advanced and recurrent disease.

Original languageEnglish (US)
Pages (from-to)353-360
Number of pages8
JournalGynecologic Oncology
Issue number2
StatePublished - Feb 2019
Externally publishedYes


  • Adaptive planning recurrent
  • Advanced
  • Gynecologic
  • High dose rate (HDR)
  • Image based
  • Interstitial brachytherapy (ISBT)

ASJC Scopus subject areas

  • Oncology
  • Obstetrics and Gynecology


Dive into the research topics of 'Inversely and adaptively planned interstitial brachytherapy: A single implant approach'. Together they form a unique fingerprint.

Cite this